6276 - 6300 of 6422 Results
Title
Year
-
OPENTitle: Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation statesJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 34Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhad408Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10793575/pdf/bhad408.pdfCitation Count: 28
-
OPENTitle: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29707Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707Citation Count: 21
-
OPENTitle: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effectJournal Name: Physical BiologyPublisher: IOP PublishingVol: 18Issue #: 1Start Page: 016002End Page: 016002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1478-3975/abb6dcBest OA location URL: https://iopscience.iop.org/article/10.1088/1478-3975/abb6dc/pdfCitation Count: 18
-
OPENTitle: Genetic diversity of axon degenerative mechanisms in models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105368End Page: 105368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105368Citation Count: 23
-
OPENTitle: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disordersJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 27Issue #: 4Start Page: 101251End Page: 101251Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.gim.2024.101251Best OA location URL: https://www.gimjournal.org/article/S1098-3600(24)00185-0/pdfCitation Count: 0
-
OPENTitle: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5573415Citation Count: 23
-
OPENTitle: Motor phenotype classification in moderate to advanced PD in BioFIND studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 178End Page: 183Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6774826Citation Count: 23
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 31
- RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A2018OPENTitle: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00417/pdfCitation Count: 43
-
OPENTitle: The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s DiseaseJournal Name: Aging, Neuropsychology, and CognitionPublisher: Informa UK LimitedVol: 27Issue #: 4Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13825585.2019.1653445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8763139Citation Count: 23
-
OPENTitle: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissuesJournal Name: Frontiers in Molecular BiosciencesPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 1087982End Page: 1087982Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmolb.2023.1087982/pdfCitation Count: 9
-
OPENTitle: Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar typeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 199End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.006Best OA location URL: http://www.prd-journal.com/article/S1353802019300379/pdfCitation Count: 25
-
OPENTitle: Current disease modifying approaches to treat Parkinson’s diseaseJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 73Issue #: 7Start Page: 1365End Page: 1379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-2101-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11108524Citation Count: 95
-
OPENTitle: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 211End Page: 219Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/211.full.pdfCitation Count: 16
-
OPENTitle: A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 7Start Page: e0254834End Page: e0254834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254834Best OA location URL: https://doi.org/10.1371/journal.pone.0254834Citation Count: 11
-
OPENTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: http://doi.org/10.1016/j.expneurol.2008.09.003Citation Count: 240
-
OPENTitle: Combining biomarkers for prognostic modelling of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 7Start Page: 707End Page: 715Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-328365Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/7/707.full.pdfCitation Count: 26
-
OPENTitle: LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf103Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf103/62298367/fcaf103.pdfCitation Count: 0
-
OPENTitle: SparkINFERNO: a scalable high-throughput pipeline for inferring molecular mechanisms of non-coding genetic variantsJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 36Issue #: 12Start Page: 3879End Page: 3881Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/bioinformatics/btaa246Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/36/12/3879/33437175/btaa246.pdfCitation Count: 13
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68
-
OPENTitle: The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemicJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 333End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01178-7Best OA location URL: https://www.nature.com/articles/s41531-025-01178-7.pdfCitation Count: 0
-
OPENTitle: FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 572End Page: 579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2018.08.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.08.006Citation Count: 83
-
OPENTitle: Population fraction of Parkinson’s disease attributable to preventable risk factorsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00603-zBest OA location URL: https://www.nature.com/articles/s41531-023-00603-z.pdfCitation Count: 10
-
OPENTitle: Aseptic, semi-sealed cranial chamber implants for chronic multi-channel neurochemical and electrophysiological neural recording in nonhuman primatesJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 420Issue #:Start Page: 110467End Page: 110467Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jneumeth.2025.110467Best OA location URL: https://doi.org/10.1016/j.jneumeth.2025.110467Citation Count: 0
-
OPENTitle: Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theoryJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00904-5Best OA location URL: https://www.nature.com/articles/s41531-025-00904-5.pdfCitation Count: 1